Arkolith/Insider Trading/QTTB/Form 4

Violette Shelia M.

Chief Scientific OfficerQ32 Bio Inc. (QTTB) · full profile →Form 4 · filed Feb 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
1 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2025Grant(A)38K—$061K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2025Disposed to issuer(D)18K—$00
Feb 24, 2025Grant(A)18K—$018K
Feb 24, 2025Disposed to issuer(D)56K—$00
Feb 24, 2025Grant(A)13K—$013K
Feb 24, 2025Disposed to issuer(D)33K—$00
Feb 24, 2025Grant(A)33K—$033K
Feb 24, 2025Disposed to issuer(D)13K—$00
Feb 24, 2025Grant(A)56K—$056K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-028245) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML